Latest NewsSep 25, 2025HiFiBiO Therapeutics to Present Updated Phase 1 Clinical Data of Two Immuno-Oncology Programs at the 2025 Annual Meeting of the European Society for Medical Oncology (ESMO) All Filter By: Year20252024202320222021202020192018201720162015Apr 18, 2022Discovery of predictive biomarkers of response to T cell-targeting biologics using ex vivo single-cell profiling coupled with TCR clonotype characterizationApr 4, 2022HiFiBiO Therapeutics Announces Three Presentations at 2022 American Association for Cancer Research (AACR) Annual MeetingJan 10, 2022HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB301001Dec 20, 2021FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 ProgramNov 1, 2021HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200301< 1 … 5 6 7 8 9 … 18 >